ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 628 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

Y. Kanai, W S Lee, Dennis Brown et al. · Journal of Clinical Investigation · 1994 · 624 citations · Full text

Life Sciences, Molecular Biology, Physiology +15

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Song‐Ping Han, Deborah Hagan, Joseph R. Taylor et al. · Diabetes · 2008 · 418 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Ligand Effects in Gold- and Platinum-Catalyzed Cyclization of Enynes:  Chiral Gold Complexes for Enantioselective Alkoxycyclization

María Paz Muñoz, Javier Adrio, Antonio M. Echavarren · Organometallics · 2005 · 300 citations

Natural Sciences, Chemistry, Catalysis +16

The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression.

Won Suk Lee, Yoshiakira Kanai, Rebecca G. Wells et al. · Journal of Biological Chemistry · 1994 · 266 citations · Full text

Life Sciences, Biochemistry, Physiology +14